These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 30265804)

  • 1. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
    Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
    ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-activated
    Liu W; Ruan ML; Liu L; Ji X; Ma Y; Yuan P; Tang G; Lin H; Dai J; Xue W
    Theranostics; 2020; 10(5):2201-2214. PubMed ID: 32104504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression.
    Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G
    Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy.
    Shao F; Wu Y; Tian Z; Liu S
    Biomaterials; 2021 Jul; 274():120869. PubMed ID: 33984636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
    Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
    Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose oxidase-mediated tumor starvation therapy combined with photothermal therapy for colon cancer.
    Zhu H; Li Y; Ming Z; Liu W
    Biomater Sci; 2021 Aug; 9(16):5577-5587. PubMed ID: 34241605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A biomimetic cascade nanoreactor for tumor targeted starvation therapy-amplified chemotherapy.
    Cheng H; Jiang XY; Zheng RR; Zuo SJ; Zhao LP; Fan GL; Xie BR; Yu XY; Li SY; Zhang XZ
    Biomaterials; 2019 Mar; 195():75-85. PubMed ID: 30616030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale dual-enzyme cascade metal-organic frameworks through biomimetic mineralization as ROS generators for synergistic cancer therapy.
    Jin S; Weng L; Li Z; Yang Z; Zhu L; Shi J; Tang W; Ma W; Zong H; Jiang W
    J Mater Chem B; 2020 Jun; 8(21):4620-4626. PubMed ID: 32373876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Targeted Cascade Nanoreactor Based on Metal-Organic Frameworks for Synergistic Ferroptosis-Starvation Anticancer Therapy.
    Wan X; Song L; Pan W; Zhong H; Li N; Tang B
    ACS Nano; 2020 Sep; 14(9):11017-11028. PubMed ID: 32786253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A biomimetic MOF nanoreactor enables synergistic suppression of intracellular defense systems for augmented tumor ablation.
    Gao P; Shi M; Wei R; Pan W; Liu X; Li N; Tang B
    Chem Commun (Camb); 2020 Jan; 56(6):924-927. PubMed ID: 31850458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistically enhanced multienzyme catalytic nanoconjugates for efficient cancer therapy.
    Yin SY; Liu W; Yang J; Li J
    J Mater Chem B; 2021 Jul; 9(29):5877-5886. PubMed ID: 34259273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
    Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
    Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy.
    Shan L; Fan W; Wang W; Tang W; Yang Z; Wang Z; Liu Y; Shen Z; Dai Y; Cheng S; Jacobson O; Zhai K; Hu J; Ma Y; Kiesewetter DO; Gao G; Chen X
    ACS Nano; 2019 Aug; 13(8):8903-8916. PubMed ID: 31374171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
    Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
    Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
    Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
    Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urchin-Shaped Metal Organic/Hydrogen-Bonded Framework Nanocomposite as a Multifunctional Nanoreactor for Catalysis-Enhanced Synergetic Therapy.
    Hu C; Wang J; Liu S; Cai L; Zhou Y; Liu X; Wang M; Liu Z; Pang M
    ACS Appl Mater Interfaces; 2021 Feb; 13(4):4825-4834. PubMed ID: 33496168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting Oxidative Stress in Cancer Starvation Therapy by Site-Specific Startup of Hyaluronic Acid-Enveloped Dual-Catalytic Nanoreactors.
    Yao Z; Zhang B; Liang T; Ding J; Min Q; Zhu JJ
    ACS Appl Mater Interfaces; 2019 May; 11(21):18995-19005. PubMed ID: 31058483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
    Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
    ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.